Cann is a provider of low dose tetrahydrocannabinol (THC) beverage used to offer all-natural flavor drinks.
Cann has raised $27.0M in total funding. The most recent round was Series A. The last funding was announced in February 2022.
Cann's investors include Imaginary Ventures, Global Founders Capital, Cosmic Venture Partners, Navy Capital, Cresco Capital Partners.
Cann is headquartered in Oakland, United States.
Cann is a provider of low dose tetrahydrocannabinol (THC) beverage used to offer all-natural flavor drinks.
Cann is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cann — Funding & Investors." VCBacked, February 15, 2022, https://www.vcbacked.co/company/cann-oakland. Accessed July 20, 2026.
VCBacked. (2022). Cann — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/cann-oakland
{{cite web |title=Cann — Funding & Investors |url=https://www.vcbacked.co/company/cann-oakland |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated